// company-profile

Aprea Therapeutics, Inc.

APRE
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings59Insiders11
// api This Aprea Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 16 insiders purchased shares. Buying was led by Peters Richard.

// 90-day insight

Over the last 90 days, Aprea Therapeutics, Inc. insiders bought $125K across 20 transactions with no open-market sales.

  • Most active insider: Peters Richard with 4 transactions totaling $100K.
  • Largest single purchase: $100K by Peters Richard on Mar 31, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Aprea Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$1.7M
QoQ change
+16.9%
Reporting period
2026-03-31
#1
AIGH Capital Management LLC
CIK 1835943
$698,240
915K shares
#2
Vestal Point Capital, LP
CIK 1974915
$267,015
350K shares
#3
SPHERA FUNDS MANAGEMENT LTD.
CIK 1496201
$205,983
270K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Peters RichardAPRE
Award
3,135$0.00$0K
Jun 16, 2026Seizinger Bernd R.APRE
Award
3,135$0.00$0K
Jun 16, 2026Peters RichardAPRE
Award
12,555$0.00$0K
Jun 16, 2026HENNEMAN JOHN B IIIAPRE
Award
12,555$0.00$0K
Jun 16, 2026Duey MarcAPRE
Award
12,555$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.